Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of novel small molecule inhibitors of centrosome clustering in cancer cells

25 Sept 2013

Abstract excerpt

// Eiko Kawamura 1 , Andrew B. Fielding 1,2 , Nagarajan Kannan 3 , Aruna Balgi 4 , Connie J. Eaves 3,5 , Michel Roberge 4 , Shoukat Dedhar 1,4 1 Department of Integrative Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada 2 current address: Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK 3 Terry Fox Laboratory, BC Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 protein interactions
Share to Cancer-related Molecular Pathways
Share to Microtubule and mitosis dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24091544
DOI: 10.18632/oncotarget.1198

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of novel small molecule inhibitors of centrosome clustering in cancer cellsPMID 24091544Read ↗

Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen.Semantic proximity Read ↗

A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cellsSemantic proximity Read ↗

Centrosome – a promising anti-cancer targetSemantic proximity Read ↗

Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death.Semantic proximity Read ↗

Mitotic Poisons In Cancer PharmacotherapySemantic proximity Read ↗

CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cellsSemantic proximity Read ↗

Mitotic kinases are emerging therapeutic targets against metastatic breast cancerSemantic proximity Read ↗

Targeting Microtubules by Natural Agents for Cancer TherapySemantic proximity Read ↗

Hitting the brakes: targeting microtubule motors in cancerSemantic proximity Read ↗

Mitotic drug targetsSemantic proximity Read ↗

How do anti-mitotic drugs kill cancer cells?Semantic proximity Read ↗

Microtubule Targeting Agents in Disease: Classic Drugs, Novel RolesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.